Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, announces that, further to the press releases dated May 23, 2024, June 20, 2024, […]
Read The Rest at :